Accessible and equitable care begins with collaboration
When health plans, medtech, pharma and other ecosystem players work together, we can improve healthcare experiences and treatment outcomes for a better future of healthcare.
Deliver what people need from healthcare experiences
Hassles are preventing healthcare consumers from having the patient experiences they want. Engaging with them in new ways opens doors to act in their best interests.
Cultivate an environment of partnerships
Consumers want their healthcare to be a partnership. They need support as they work to adopt healthier lifestyles and to improve preventive health.
Work together to improve healthcare for all
Organizational partnerships can help address the root causes of health disparities. Consider potential collaborations involving solutions such as AI and digital health.
Insights
WEBINAR
How pharma can leverage AI to shape the future of health
Join our expert panelists as they unpack the promise of AI in the healthcare ecosystem and how it can overcome adoption barriers to realize that promise.
Webinar
How medtech can leverage AI to shape the future of health
Learn how medtech can create confidence in AI by leveraging it to create innovative products that drive better outcomes and increase customer centricity and operational effectiveness.
Pharmaceuticals & Biotech
3 pathways to transform the patient experience
Pharma is seeing a heightened focus on elevating PSP capabilities to drive a more compelling patient experience. But lasting impacts for businesses and patients require a comprehensive program perspective and focused, tangible efforts. The authors discuss ZS’s PSP transformation framework as well as three pathways have that have helped pharma organizations lead successful PSP transformations.
Webinar
How health plans can lead the industry to truly connected healthcare
Health plans have invested billions into integrated care models, mobile apps and devices meant to improve treatment experiences. We dive into why these aren’t transforming outcomes yet and what you can do to deliver what people want from their care.
Webinar
More than medicine: Biopharma’s role in a more connected, outcomes-focused world
ZS research found that 72% of U.S. adults want preventive care and are willing to share personal health data to get it. What role can biopharma play to create value in a future that demands moving from treating illness to holistic health outcomes?
- A
- E
- B
- c
- D
Building connections to reimagine healthcare
Watch our video to see what people want from the future of health.
How the industry can deliver connected health
There’s great potential to form innovative partnerships and take actions across the ecosystem that will position us to build the kind of healthcare system we’d all like to see. Let’s work together to bridge healthcare gaps.
“Consumers in the U.K., Germany and Sweden told us they want stronger relationships with their healthcare providers than they’re experiencing. Physicians should be spending less time struggling with unintuitive technology and more time caring for patients.”
“I would like to see the healthcare industry stop thinking about healthcare as a place you go to receive a thing and instead think about it as a state that we’re seeking.”
“There’s no other constituent that has a better view of the entire healthcare system than health plans. They need to continue their efforts to go beyond explaining benefits to explaining how to help people better navigate the system.”
“There is tremendous appetite across healthcare organizations to partner toward health equity and expand collective impact. I encourage organizations to be bold! Know there will be stops and starts but if everyone keeps pushing, we will make progress.”
“Integrated care models are gaining ground and becoming a global trend. When financial incentives, performance and the greater good are part of the discussion, you tend to get good results.”
“Biopharma has advanced capabilities to understand and engage with the stakeholders who have the agency to champion connected health. The key will be reframing how biopharma partners to unlock the value of the whole-person-centered future of health at scale.”
- section 1
- section 2